Moxifloxacin injection - Fresenius Kabi
Latest Information Update: 23 Dec 2021
Price :
$50 *
At a glance
- Originator Fresenius Kabi
- Class Antibacterials; Azabicyclo compounds; Cyclopropanes; Fluoroquinolones; Piperidines; Pyrrolidines; Small molecules
- Mechanism of Action DNA gyrase inhibitors; Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Acute exacerbations of chronic bronchitis; Acute sinusitis; Community-acquired pneumonia; Intra-abdominal infections; Skin and soft tissue infections
Most Recent Events
- 14 Sep 2015 Launched for Acute exacerbations of chronic bronchitis in USA (IV)
- 14 Sep 2015 Launched for Acute sinusitis in USA (IV)
- 14 Sep 2015 Launched for Community-acquired pneumonia in USA (IV)